Schroder Investment Management Group’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$20.1M	Buy	39,852 +10,801	+37%	+$5.16M	0.02%	533
2025 Q4	$17M	Buy	29,051 +12,439	+75%	+$6.35M	0.01%	546
2025 Q3	$7.36M	Sell	16,612 -16,595	-50%	-$6.19M	0.01%	712
2025 Q2	$10M	Buy	33,207 +2,801	+9%	+$835K	0.01%	636
2025 Q1	$9.97M	Buy	30,406 +19,359	+175%	+$6.36M	0.01%	642
2024 Q4	$3.44M	Sell	11,047 -9,795	-47%	-$2.75M	﹤0.01%	843
2024 Q3	$4.43M	Buy	20,842 +8,134	+64%	+$2.08M	﹤0.01%	804
2024 Q2	$3.56M	Sell	12,708 -10,993	-46%	-$2.62M	﹤0.01%	840
2024 Q1	$6.33M	Buy	23,701 +5,401	+30%	+$1.27M	0.01%	739
2023 Q4	$4.23M	Buy	+18,300	New	+$3.2M	0.01%	798
2020 Q1	–	Sell	-981	Closed	-$89K	–	1358
2019 Q4	$89K	Buy	+981	New	+$95.1K	﹤0.01%	1212